Glycoproteins as markers of inflammation in rheumatic disorders
Kulkarni, A.V.; Engineer, J.J.; Sequira, R.D.; Borges, N.E.; Joshi, V.R.
Journal of Postgraduate Medicine 32(2): 89-93
1986
ISSN/ISBN: 0022-3859 PMID: 3761215 Document Number: 267712
Document emailed within 1 workday
Related Documents
Osada, J.; Zawirska, B.; Chorazyczewski, J.; Dobryszycka, W. 1981: Catabolism of desialylated glycoproteins during carcinogenesis and inflammation in rats Acta Biochimica Polonica 28(2): 147-156Chiappo, G.F.; Licata, D.; Mignone, F. 1976: Screening for rheumatic fever in childhood. Study on levels of various glycoproteins Minerva Pediatrica 28(40): 2491-2506
Pos, O.; van Dijk, W.; Ladiges, N.; Linthorst, C.; Sala, M.; van Tiel, D.; Boers, W. 1988: Glycosylation of four acute-phase glycoproteins secreted by rat liver cells in vivo and in vitro. Effects of inflammation and dexamethasone European Journal of Cell Biology 46(1): 121-128
Rassokhina, I.I.; Andreeva, L.N.; Kuz'mina, N.N.; Mikhaĭlova, I.N.; Avdeeva, Z.I. 1980: Humoral and cellular immunologic reactions to structural glycoproteins of the heart valves in active rheumatic heart disease Terapevticheskii Arkhiv 52(10): 123-126
Le Roy, F.; Barbier, S.; Passos, E.M.; Godin, M. 2003: Inflammation markers in daily practice Nephrologie 24(7): 347-350
Volpato, S.; Fellin, R. 2005: Alcohol consumption and circulating markers of inflammation Recenti Progressi in Medicina 96(2): 102-107
Selcuk, M.T.; Selcuk, H.; Maden, O.; Temizhan, A.; Aksu, T.; Dogan, M.; Sasmaz, A. 2007: Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis Journal of Heart Valve Disease 16(5): 468-474
Fareed, J.; Bick, R.L.; Squillaci, G.; Walenga, J.M.; Bermes, E.W. 1983: Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disorders Clinical Chemistry 29(9): 1641-1658
Semenchenko, I.I.; Sharafetdinov, K.K.; Plotnikova, O.A.; Alekseeva, R.I.; Sentsova, T.B.; Vorozhko, I.V. 2013: Markers of immune inflammation in patients with type 2 diabetes and obesity Voprosy Pitaniia 82(5): 46-50
Poriadin, G.V.; Salmasi, Z.M.; Kazimiskiĭ, A.N. 2006: Activation markers of lymphocytes as indicators of immune system dysregulation in inflammation Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 2-7
Lavín-Gómez, B.A.; Palomar-Fontanet, R.; Gago-Fraile, M.; Quintanar-Lartundo, J.é A.; Gómez-Palomo, E.ía.; González-Lamuño, D.; García-Unzueta, M.T.; Arias-Rodríguez, M.A.; Gómez-Gerique, J.A. 2011: Inflammation markers, chronic kidney disease, and renal replacement therapy Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 27: 33-37
Kazar, J.; Kovacova, E.; Koncova, K.; Cvachova, S.; Mongiellova, V.; Lietava, J.; Simko, F. 2005: Chlamydia pneumoniae antibodies and markers of inflammation in patients with cardiovascular diseases Bratislavske Lekarske Listy 106(11): 341-344
Ortíz Leyba, C.; Rodríguez-Piñero, J.; Díaz, J.P.; Sanchez Guijo, P.; Ortíz, J.V.; Núñex Castain, C.; Medina Redondo, F. 1974: Glycoproteins and liver. I. Behavior of the spectrum of serum glycoproteins in hepatic cirrhosis Revista Clinica Espanola 134(4): 343-350
Nevzorova, V.A.; Prosekova, E.V.; Gel'tser, B.I.; Luk'ianov, P.A.; Shestovskaia, T.N.; Maĭstrovskaia, I.V.; Arzamastseva, A.I. 2001: Changes in biochemical inflammation markers in evaluation of the effectiveness of basic chemotherapy in bronchial asthma Terapevticheskii Arkhiv 73(3): 24-27
Bumbăcea, D.ş 2004: Non-invasive markers in evaluating inflammation and remodeling in lung diseases. 1. Induced sputum Pneumologia 53(4): 182-188
Topchii, I.; Semenovykh, P.; Galchiskaya, V.; Yakymenko, Y.; Shcherban, T. 2019: Association of Fibroblast Growth Factor 23 with Markers of Inflammation and Fibrosis in Diabetic Nephropathy Georgian Medical News 2019(292-293): 44-49
Niehues, T.; Horneff, G.; Michels, H.; Sailer Höck, M.; Schuchmann, L. 2004: Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria Zeitschrift für Rheumatologie 63(2): 147-158
Burón, E.; Garrote, J.A.; Arranz, E.; Oyágüez, P.; Fernández Calvo, J.L.; Blanco Quirós, A. 1999: Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome Allergologia et Immunopathologia 27(1): 11-17
Koenig, W. 2002: Insulin resistance, heart disease and inflammation. Identifying the 'at-risk' patient: the earlier the better? the role of inflammatory markers International Journal of Clinical Practice. Suppl 132: 23-30
Takatsu, T.; Kino, M.; Tsujimoto, G.; Kaku, K.; Sonotani, N.; Suwa, M.; Morita, H.; Hirota, Y.; Tsutsumi, J.; Kubo, S.; Kawamura, K. 1979: Recurrence of rheumatic fever and valvular diseases--etiology of rheumatic fever, rheumatic carditis and recurrent rheumatic fever Nihon Rinsho. Japanese Journal of Clinical Medicine 37(8): 3082-3102